Purpose of review To discuss capsular tension devices and recent evidence regarding their use.
INTRODUCTION
The success of cataract surgery may be uncertain when threatened by zonular weakness which increases the intraoperative risk of vitreous prolapse, capsular rupture, and retained lens material, as well as the postoperative risk of intraocular lens (IOL) dislocation. Capsular tension rings (CTRs) and related endocapsular devices allow surgeons to approach zonular weakness during complex cataract surgery with improved safety and have become a well established tool in the armamentarium of cataract surgeons.
Nagamoto and Bissen-Miyajima [1, 2] as well as Hara et al. [3, 4] initially developed the capsular bag supporting ring independently in Japan around 1990. Although their original intent was for a device designed to maintain the circular contour of the capsular bag, they also created an effective new approach for managing zonular weakness. In 1993, Legler and Witschel [5] were the first to present the placement of an open-ringed poly(-methyl methacrylate) (PMMA) CTR in a human eye during cataract surgery. There are now multiple variations of this simple, innovative device and their use is widespread.
MECHANICS OF CAPSULAR TENSION RINGS
The CTR is a PMMA open-ring device with blunttipped eyelets at its ends. A CTR can be inserted at any point during cataract surgery following creation of a strong anterior capsulotomy created via capsulorhexis or femtosecond laser and can serve to support the capsular bag during surgery as well as provide long-term IOL stabilization.
The diameter of the open-ring is designed to be greater than that of the capsular bag when in its final position. The CTR creates an equally distributed centrifugal force to the equator of the bag. Thereby, the CTR recruits tension from stronger zonules to buttress areas of weak or absent zonules, stabilizing the entire complex. This distribution of support may recenter a mildly subluxed capsular bag, but it will not recenter a severely subluxed capsular bag nor will it cure a progressive zonulopathy. In these situations, a modified CTR (MCTR) or a capsular tension segment (CTS) provides a stable long-term solution through scleral-fixation. A CTR decreases the prevalence of posterior capsule opacification (PCO) following cataract surgery [6] . Whether a CTR will decrease the rate capsular contraction syndrome is still being evaluated (see below).
INDICATIONS AND CONTRAINDICATIONS
Any cause of zonular weakness or loss may be an indication for CTR placement. The most common a The Eye Institute of Utah and b causes of zonular insufficiency being pseudoexfoliation syndrome, trauma, previous ocular surgery (e.g., filtering surgery or vitrectomy), hypermature cataracts, and increased axial length [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . Less common causes include Marfan's syndrome, homocystinuria, Weill-Marchesani syndrome, microspherophakia, retinitis pigmentosa, and intraocular neoplasms [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] .
If there exists significant decentration or phakodonesis, a standard CTR is not likely to provide adequate support. When these conditions exist, a scleral fixation CTR design will result in better longterm centration and stabilization.
A contraindication to the use of a CTR is an anterior or posterior capsular tear. In the setting of a noncontinuous capsular tear, the centrifugal force generated by the ring may cause tear extension and risk loss of the CTR to the posterior segment [33] . It may be possibly to utilize a CTS in these cases [13, 14] .
DEVICE TYPES
The following section will discuss the available types of endocapsular support devices.
Standard capsular tension ring
The general structure and mechanics of the standard CTR are discussed above. Both Morcher GmbH (Stuttgart, Germany) and Ophtec (Groningen, The Netherlands) manufacture CTRs and are approved by the US Food and Drug Administration. The Morcher ring is currently distributed in the USA by FCI Ophthalmics (Pembroke, Massachusetts, USA) and Alcon Laboratories, Inc. (Fort Worth, Texas, USA) and is available in three sizes: 12.3 mm (compresses to 10.0 mm), 13.0 mm (compresses to 11.0 mm), and 14.5 mm (compresses to 12.0 mm). The Ophtec ring is distributed in the United States by Abbot Medical Optics (Irvine, California, USA) and is available in a 13-mm ring (compresses to 11 mm) and a 12.0-mm ring (compresses to 10.0 mm). Insertion of the ring can be accomplished manually with forceps, or using an injector. All of the above rings are also available in a preloaded, single-use injector, which is our preferred method of insertion. Geuder (Heidelberg, Germany) and Ophtec make reusable injectors designed for onehanded implantation of the CTRs (Ophtec CTRs are not compatible with the Geuder injector).
A modification of the standard CTR design is the Henderson Ring [34] , which features eight equally spaced indentations spanning the circumference of the ring, creating a sinusoidal shape. The indentations allow for nuclear and cortical material removal while still maintaining the desired stretch of the capsular bag.
Selecting capsular tension ring size Capsular bag dimensions dictate the size of CTR selected. Overlap of the terminal eyelets is required for maximum circumferential support. As shown by Vass et al. [35] and others [36] , the size of the capsular bag correlates with globe axial length and corneal diameter. As such, horizontal white-towhite and axial length measurements should guide a surgeon's CTR selection. Using a larger sized CTR ensures overlap of end terminals but may be more challenging to insert.
Modified capsular tension ring
The MCTR [37] was developed as a solution to profound zonular insufficiency, allowing surgeons to anchor an intact capsular bag to the scleral wall. As with the standard CTR, the MCTR utilizes a PMMA open-ring design, but, unlike the standard CTR, there are one or two fixation eyelets attached to the ring, which allow it to be sutured to the sclera. The eyelets protrude 0.25 mm forward from the ring of the CTR and sit anterior to the anterior capsule. A more recent modification designed by Malyugin [38] incorporates a pigtail curve at the terminus of one end of the ring such that the fixation eyelet rests at a plane anterior to the plane of the remainder of the ring. This design allows for insertion with an injector. An adequately sized capsulotomy (5-6.5 mm) is desired to ensure safe removal of the cataract, stable positioning of the ring, and proper interface of the hook of the MCTR eyelet with the capsulorhexis margin [13] .
Capsular tension segment
Similar to the MCTR, the CTS was also created for patients with extensive and/or progressive zonular loss [13, 14] . The partial PMMA ring segment spans a 1208 arc with a radius of 4.5 or 5 mm with an anteriorly positioned fixation eyelet. Unlike the CTR and MCTR, the CTS can be utilized in cases KEY POINTS Endocapsular support devices available for cataract surgery in the setting of zonular instability include the CTR, MCTR, and CTS.
The choice of capsular tension device in a particular surgery depends on the amount of zonular compromise as well as the likelihood of progression.
Capsular tension devices aid in improving intraoperative safety and in achieving long-term stability of cataract surgery in the setting of zonular weakness or loss in both pediatric and adult patients.
where a discontinuous capsulorhexis, anterior capsule tear, or a posterior capsule tear is present, as it does not generate a 3608 expansile force. Multiple CTSs can be used when necessary. The CTS provides support in the transverse plane, and must be combined with a CTR or MCTR when circumferential support is required. The CTS may also be used for intraoperative support and removed prior to completion of the case. The CTS is available in two different radii of curvature: 4.5 mm (model 6E) and 5.0 mm (model 6D).
CHOICE OF DEVICE AND TIMING OF PLACEMENT
Choice of capsular tension device in a particular situation depends on the cause of capsular bag instability as well as surgeon comfort and preference regarding the available device options. Progressive zonular disorders (e.g., pseudoexfoliation, Marfan's syndrome) should be thought of as separate from nonprogressive zonular defects (e.g., prior trauma, iatrogenic). One must also consider the amount of zonular loss or generalized zonular instability.
In cases where the remaining zonules are expected to be strong, a standard CTR may allow for adequate redistribution of zonular force, compensating for an area of zonular weakness or dialysis [7, 11, 12, 15] . More generally, CTRs are indicated in cases of mild, diffuse zonular weakness or small, localized zonular dialysis (generally less than 4 clock hours). In more advanced or progressive zonulopathies, a scleral-fixated MCTR or CTS paired with a CTR likely provides the best long-term solution [13,37,39,40 & -42 & ]. Timing of placement may also dictate the type of device used. Early ring placement provides capsular distension to prevent capsular bag collapse during phacoemulsification or cortex aspiration [7, 10] . Placement of a CTR or MCTR requires the device to be dialed into position, which may require more manipulation prior to or during phacoemulsification and thus cause zonular trauma. Ahmed et al. [43] demonstrated that early CTR placement leads to greater zonular stress and iatrogenic zonular trauma when compared with CTR placement after cataract and cortex removal. Early ring placement also makes cortex removal difficult. If early placement is necessary, one might consider a Henderson CTR or a CTS to allow for greater ease of aspiration of cortex. In addition, a CTS can be placed relatively atraumatically on account of its smaller size, requiring less manipulation for adequate positioning. In the setting of an anterior or posterior capsular tear, which are contraindications to the use of a CTR or MCTR, a CTS can be used due its transverse force rather than circumferential force.
METHOD OF INSERTION
As stated above, it is the preference of the authors to utilize single-use injectors with a preloaded CTR. When a case requires placement of an MCTR, it is our current preference to inject a preloaded Morcher type 10L preloaded with suture. Our method for scleral fixation is a variation of an ab externo technique previously described by Slade et al. [44 && ]. This technique uses a microvitreoretinal blade to create sclerotomies and an internal limiting membrane forceps or Condon Snare (MicroSurgical Technology, Redmond, Washington, USA) to retrieve a CV-8 expanded polytetrafluoroethylene (GORE-TEX, not labeled for ophthalmic use) or 9-0 polypropylene suture prepassed through the eyelet of the MCTR. This same method of fixation is also our preference for CTS fixation.
INTRAOPERATIVE AND POSTOPERATIVE CAPSULAR STABILITY
Early studies of CTRs demonstrated their range of use, level of safety and effectiveness and have been reviewed previously [13, 18] . The agreement from these earlier papers was that a CTR improves capsular stability, decreases intraoperative adverse events, and maintains postoperative IOL centration in the setting of mild zonular weakness or loss.
More recent papers include a case-series of 17 eyes [16] with varying degrees of traumatic zonular dialysis with a mean follow up period of nearly 26 months, which demonstrated IOL stability and centration over time. In a small case-control series, Takimoto et al. [45] found no significant differences in the mean degree of IOL decentration, tilt angle, anterior capsule opening area, or refractive prediction error when comparing eyes with zonular instability requiring CTR implantation during cataract surgery to fellow eyes without zonular instability. In 2013, Wang et al. [21] shared their results of a retrospective review of 84 eyes of 82 patients receiving a CTR during cataract surgery. The main indications for CTR insertion were previous trauma, pseudoexfoliation syndrome, and mature cataracts. An IOL was successfully implanted in the bag in 72 eyes (85.7%). A posterior capsule tear was the most common intraoperative complication (3.6%). Postoperatively, the most common complications were a decentered IOL (8.3%) and persistent corneal edema (6.0%). Overall, 61 eyes (72.6%) had better postoperative visual acuity compared with preoperative acuity, with 67 patients (79.8%) achieving vision of 20/40 or better. These recent studies demonstrate that in eyes with zonular dehiscence or weakness, a CTR can prevent marked IOL decentration, tilt and severe anterior capsule contraction, and may lead to prevention of a refractive prediction error.
The body of evidence supporting the safety and use of CTRs in children has also continued to expand. In 2009, Das et al. [29] prospectively followed 18 eyes of 15 children with subluxation of crystalline or cataractous lenses between 90-2108 after phacoemulsification, CTR and IOL implantation. Sixteen eyes had a best corrected visual acuity (BCVA) of 20/40 or better. Nine eyes developed PCO and were managed with Neodymium Yttrium Aluminum Garnet laser posterior capsulotomy. One eye had IOL dislocation after 2 years.
REFRACTIVE OUTCOME
Several studies have sought to describe CTR impact on refractive outcomes.
Boomer and Jackson [46] found no statistical difference in refractive predictive errors in a small case-control series leading them to conclude that use of a CTR had no consistent effect on refractive outcome and modification of IOL power calculations was unnecessary. In a separate publication [47] , they also demonstrated that following CTR placement, the CTR and IOL remained in the bag with the CTR positioned between the IOL haptics and the ciliary body.
In 2009, Rohart and Gatinel [48] found in uneventful cataract surgery that a CTR does not improve the optical quality of the pseudophakic eye. Subsequently, Schild et al. [49] compared refractive outcomes in myopic eyes between phacoemulsification and IOL implantation with and without a CTR. There was no statistically significant difference in the mean absolute refractive prediction error between the CTR group and the control, but there was lower variance in the absolute refractive prediction error in the CTR group. They concluded that a CTR had no consistent effect on refractive outcomes in highly myopic eyes, although there was a tendency toward higher precision in outcomes with a CTR. As with Boomer and Jackson, their results indicated that the IOL power calculation does not have to be changed when a CTR is used.
Mastropasqua et al. [50] demonstrated in a 2013 prospective, randomized trial of 60 eyes that an inclusion of a CTR implant paired with a diffractive multifocal IOL reduced the ocular wavefront error related to a reduction of third-order aberration when compared to multifocal IOL placement alone. The authors attributed this reduced wavefront error to better IOL position.
LATE SPONTANEOUS IN-THE-BAG INTRAOCULAR LENS AND CAPSULAR TENSION RING DISLOCATION
Capsular contraction syndrome was an early reported postoperative possibility despite attempted prevention with CTR placement [24, 25, 51, 52] and, along with pseudoexfoliation, is a leading risk factor for late spontaneous in-the-bag IOL dislocation [53, 54] . More recent publications have sought to describe the conditions leading to subluxation or dislocation despite CTR use.
In a 2012 retrospective case series, Werner et al. [55 && ] described the clinical and pathologic findings from cases of in-the-bag CTR and IOL subluxation or dislocation. Patients were an average age of 76 years at explantation, which was performed 6.8 years after implantation. The IOLs in these cases were of varying designs and materials. Associated ocular conditions included pseudoexfoliation (n ¼ 17), glaucoma (n ¼ 4), vitrectomy/retina surgery (n ¼ 3), and trauma (n ¼ 1). Moderate-to-severe degrees of Soemmering's ring formation and capsulorhexis phimosis were observed or reported in 13 and 11 specimens, respectively. Fourteen eyes were implanted and explanted by the same surgeon, with an interval of approximately 7.75 years between the procedures, equating to a 0.76% rate of explantation of the CTRs implanted during the time considered. ] published a retrospective, observational case series of 13 consecutive pediatric patients (19 eyes) who underwent placement of in-the-bag IOL with either an MCTR or a CTS in conjunction with a conventional CTR. An MCTR was implanted in five eyes and a CTS with an unsutured CTR was implanted in 12 eyes; in two eyes, a CTS alone was placed. The mean BCVA at the final follow-up was significantly better than preoperatively, with the BCVA at final follow-up being 20/40 or better in 18 eyes (94.7%). All IOLs were well centered. PCO developed in 11 eyes (57.9%), with nine eyes (47.4%) requiring Neodymium Yttrium Aluminum Garnet capsulotomy, and three eyes (15.8%) requiring pars plana vitrectomy and posterior capsulotomy.
MODIFIED CAPSULAR TENSION RING AND CAPSULAR TENSION SEGMENT: RECENT LITERATURE
The above studies provide additional evidence that the use of an MCTR or CTS with CTR is a safe and effective technique for visual rehabilitation in subluxed crystalline lenses in both adult and pediatric patients.
CONCLUSION
Zonular instability during phacoemulsification can effectively be managed intraoperatively and postoperatively using a capsular tension device. Determining the proper capsular tension device depends on the amount of zonular loss, the likelihood of progressive weakness, as well as capsular integrity. Future research to better characterize the common factors leading to postoperative complications despite use of a capsular tension device will allow for enhanced surgical planning and aid in choice of endocapsular support device employed in cases of zonular instability.
